9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP): A novel agent with anti-human immunodeficiency virus activity in vitro and potent anti-moloney murine sarcoma virus activity in vivo

Lieve Naesens; Jan Balzarini; Ivan Rosenberg; Antonı́n Holý; De Clercq Erik

doi:10.1007/bf01975167

RDLNetworkEkosistem

Hakkımızda SSS

Giriş yap Başla

Hakkımızda SSS Gizlilik Şartlar İletişim

9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP): A novel agent with anti-human immunodeficiency virus activity in vitro and potent anti-moloney murine sarcoma virus activity in vivo — Lieve Naesens (1989) | RDL Network

Back

Home
Publications
9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP): A novel agent with anti-human immunodeficiency virus activity in vitro and potent anti-moloney murine sarcoma virus activity in vivo

Shared by

De Clercq Erik

KU Leuven

9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP): A novel agent with anti-human immunodeficiency virus activity in vitro and potent anti-moloney murine sarcoma virus activity in vivo

Article 1989 en

Authors

LN
Lieve Naesens
JB
Jan Balzarini
IR
Ivan Rosenberg

Discussion(0)

No comments yet. Be the first to comment.

Publication Info

DOI: 10.1007/bf01975167
Year: 1989
Published: —
Language: en

Article Details

Volume: 8
Issue: 12
Link Of The Paper: https://doi.org/10.1007/bf01975167

Timeline

Created:

Related publications

Article1989

Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent.

Jan Balzarini, Lieve Naesens, Piet Herdewijn, Ivan Rosenberg, Antonı́n Holý, Rudi Pauwels, Masanori Baba, David G. Johns, De Clercq Erik

Article1999

N6-cyclopropyl-PMEDAP: a novel derivative of 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) with distinct metabolic, antiproliferative, and differentiation-inducing properties

Sigrid Hatse, Lieve Naesens, De Clercq Erik, Jan Balzarini

Article1991

Single-dose administration of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) in the prophylaxis of retrovirus infection in vivo

Lieve Naesens, Jan Balzarini, De Clercq Erik

Article1993

Activity of the anti-HIV agent 9-(2-phosphonyl-methoxyethyl)-2,6-diaminopurine against cytomegalovirus in vitro and in vivo

Johan Neyts, F S Stals, C. A. Bruggeman, De Clercq Erik

Article1995

(R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine is a potent inhibitor of feline immunodeficiency virus infection

Thomas W. Vahlenkamp, A. de Ronde, Jan Balzarini, Lieve Naesens, De Clercq Erik, M J van Eijk, M. C. Horzinek, Herman Egberink

June 19, 2026